Association of total bilirubin and prognosis in disorders of consciousness.
Disorders of consciousness
Minimally conscious state
Prognosis
Total bilirubin
Unresponsive wakefulness syndrome
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
29 Aug 2024
29 Aug 2024
Historique:
received:
21
03
2024
accepted:
26
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Accurate prediction of the recovery of Disorders of Consciousness (DoC) is of paramount significance for clinicians and families. Serum total bilirubin (TBIL) formed by activation of heme oxygenase 2, is associated with incidence and prognosis of cardiovascular and cerebrovascular diseases. However, studies that based TBIL and DoC are limited. The study attempted to examine the association between serum TBIL levels and prognosis in patients with DoC. One hundred and sixty-eight patients with DoC in the Second hospital of Shandong University from June 2021 to June 2023 were recruited. The clinical characteristics and venous blood samples were collected within 24 h after admission. The diagnosis of DoC was determined by two skilled investigators employing various behavioral evaluations along the coma recovery scale-revised (CRS-R) and the investigators conducted follow-up assessments of diagnosis at 1, 3, and 6 months after admission. For statistical analysis, we categorized patients with an improvement in clinical diagnosis from study entry as having a "good outcome". In total, 139 individuals enrolled in the study. The median TBIL level was 8.2 μmol/L. Good recovery of DoC at 1, 3, and 6 months occurred in 25 (18.0%), 41 (29.5%), and 56 (40.3%) patients, respectively. After full adjustment, a significant association was found between TBIL levels and the prognosis of DoC at 1, 3, and 6 months. When TBIL levels were analyzed as categorical variables, an increasing trend in the tertiles of TBIL levels demonstrated a significant positive association with the recovery of DoC at 1, 3, and 6 months. Stratified analysis revealed that the association between serum TBIL levels and the recovery of DoC remained consistent across different sub-populations. A high serum TBIL level is associated with an improved likelihood of recovery of DoC. Additional research is required to elucidate the underlying pathophysiological causal association between TBIL levels and DoC.
Identifiants
pubmed: 39209971
doi: 10.1038/s41598-024-71124-9
pii: 10.1038/s41598-024-71124-9
doi:
Substances chimiques
Bilirubin
RFM9X3LJ49
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20071Subventions
Organisme : the National Key Research and Development Program of China
ID : 2020YFC2006104
Informations de copyright
© 2024. The Author(s).
Références
Piccione, F. et al. Behavioral and neurophysiological effects of repetitive transcranial magnetic stimulation on the minimally conscious state: A case study. Neurorehabil. Neural Repair 25(1), 98–102 (2011).
doi: 10.1177/1545968310369802
pubmed: 20647501
Huang, W. et al. Transcranial magnetic stimulation in disorders of consciousness: An update and perspectives. Aging Dis. 14(4), 1171–1183 (2023).
pubmed: 37163434
pmcid: 10389824
Bender, A. et al. The neurological rehabilitation of adults with coma and disorders of consciousness. Dtsch. Arztebl. Int. 120(37), 605–612 (2023).
pubmed: 37434290
pmcid: 10568738
Edlow, B. L., Claassen, J., Schiff, N. D. & Greer, D. M. Recovery from disorders of consciousness: mechanisms, prognosis and emerging therapies. Nat. Rev. Neurol. 17(3), 135–156 (2021).
doi: 10.1038/s41582-020-00428-x
pubmed: 33318675
Owen, A. M. Disorders of consciousness. Ann. N. Y. Acad. Sci. 1124, 225–238 (2008).
doi: 10.1196/annals.1440.013
pubmed: 18400933
Racine, E., Rodrigue, C., Bernat, J. L., Riopelle, R. & Shemie, S. D. Observations on the ethical and social aspects of disorders of consciousness. Can. J. Neurol. Sci. 37(6), 758–768 (2010).
doi: 10.1017/S0317167100051416
pubmed: 21059536
Rovlias, A. & Kotsou, S. Classification and regression tree for prediction of outcome after severe head injury using simple clinical and laboratory variables. J. Neurotrauma 21(7), 886–893 (2004).
doi: 10.1089/0897715041526249
pubmed: 15307901
Bagnato, S., Prestandrea, C., D’Agostino, T., Boccagni, C. & Rubino, F. Somatosensory evoked potential amplitudes correlate with long-term consciousness recovery in patients with unresponsive wakefulness syndrome. Clin. Neurophysiol. 132(3), 793–799 (2021).
doi: 10.1016/j.clinph.2021.01.006
pubmed: 33578338
Comanducci, A. et al. Clinical and advanced neurophysiology in the prognostic and diagnostic evaluation of disorders of consciousness: Review of an IFCN-endorsed expert group. Clin. Neurophysiol. 131(11), 2736–2765 (2020).
doi: 10.1016/j.clinph.2020.07.015
pubmed: 32917521
Amin, S. B. Clinical assessment of bilirubin-induced neurotoxicity in premature infants. Semin. Perinatol. 28(5), 340–347 (2004).
doi: 10.1053/j.semperi.2004.09.005
pubmed: 15686265
Pineda, S. et al. Association of serum bilirubin with ischemic stroke outcomes. J. Stroke Cerebrovasc. Dis. 17(3), 147–152 (2008).
doi: 10.1016/j.jstrokecerebrovasdis.2008.01.009
pubmed: 18436156
pmcid: 2731670
Kapitulnik, J. Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol. Pharmacol. 66(4), 773–779 (2004).
doi: 10.1124/mol.104.002832
pubmed: 15269289
Ziberna, L., Martelanc, M., Franko, M. & Passamonti, S. Bilirubin is an endogenous antioxidant in human vascular endothelial cells. Sci. Rep. 6, 29240 (2016).
doi: 10.1038/srep29240
pubmed: 27381978
pmcid: 4933905
Fu, K., Garvan, C. S., Heaton, S. C., Nagaraja, N. & Dore, S. Association of serum bilirubin with the severity and outcomes of intracerebral hemorrhages. Antioxidants (Basel) 10(9), 1346 (2021).
doi: 10.3390/antiox10091346
pubmed: 34572977
Chen, Z., He, J., Chen, C. & Lu, Q. Association of total bilirubin with all-cause and cardiovascular mortality in the general population. Front. Cardiovasc. Med. 8, 670768 (2021).
doi: 10.3389/fcvm.2021.670768
pubmed: 34222369
pmcid: 8253250
Novak, P., Jackson, A. O., Zhao, G. J. & Yin, K. Bilirubin in metabolic syndrome and associated inflammatory diseases: New perspectives. Life Sci. 257, 118032 (2020).
doi: 10.1016/j.lfs.2020.118032
pubmed: 32621920
Estraneo, A. et al. Multicenter prospective study on predictors of short-term outcome in disorders of consciousness. Neurology 95(11), e1488–e1499 (2020).
doi: 10.1212/WNL.0000000000010254
pubmed: 32661102
pmcid: 7713739
Rosanova, M. et al. Sleep-like cortical OFF-periods disrupt causality and complexity in the brain of unresponsive wakefulness syndrome patients. Nat. Commun. 9(1), 4427 (2018).
doi: 10.1038/s41467-018-06871-1
pubmed: 30356042
pmcid: 6200777
Bai, Y. et al. Breakdown of oscillatory effective networks in disorders of consciousness. CNS Neurosci. Ther. 30, e14469 (2023).
doi: 10.1111/cns.14469
pubmed: 37718541
pmcid: 10916448
Shou, F. et al. Study protocol: Developing telephone follow-up scale for patients with disorders of consciousness. Front. Public Health. 11, 1071008 (2023).
doi: 10.3389/fpubh.2023.1071008
pubmed: 37064695
pmcid: 10097956
Bossers, S. M. et al. Face-to-face versus telephonic extended glasgow outcome score testing after traumatic brain injury. J. Head Trauma Rehabil. 36(3), E134–E138 (2021).
doi: 10.1097/HTR.0000000000000622
pubmed: 33201032
Wannez, S. et al. Prevalence of coma-recovery scale-revised signs of consciousness in patients in minimally conscious state. Neuropsychol. Rehabil. 28(8), 1350–1359 (2018).
doi: 10.1080/09602011.2017.1310656
pubmed: 28399715
Chen, C. et al. Dynamic changes of brain activity in different responsive groups of patients with prolonged disorders of consciousness. Brain Sci 13(1), 5. https://doi.org/10.3390/brainsci13010005 (2022).
doi: 10.3390/brainsci13010005
pubmed: 36671987
pmcid: 9856292
Huang, W. et al. Transcranial magnetic stimulation in disorders of consciousness: An update and perspectives. Aging Dis. 14(4), 1171–1183 (2023).
pubmed: 37163434
pmcid: 10389824
Bagnato, S. & Boccagni, C. Cerebrospinal fluid and blood biomarkers in patients with post-traumatic disorders of consciousness: A scoping review. Brain Sci. 13(2), 364. https://doi.org/10.3390/brainsci13020364 (2023).
doi: 10.3390/brainsci13020364
pubmed: 36831907
pmcid: 9954419
Mele, C. et al. Thyrotropic axis and disorders of consciousness in acquired brain injury: A potential intriguing association?. Front. Endocrinol. (Lausanne) 13, 887701 (2022).
doi: 10.3389/fendo.2022.887701
pubmed: 35872992
Walder, B. et al. The prognostic significance of the serum biomarker heart-fatty acidic binding protein in comparison with s100b in severe traumatic brain injury. J. Neurotrauma 30(19), 1631–1637 (2013).
doi: 10.1089/neu.2012.2791
pubmed: 23590685
Zhao, K. et al. Association between bilirubin levels with incidence and prognosis of stroke: A meta-analysis. Front. Neurosci. 17, 1122235. https://doi.org/10.3389/fnins.2023.1122235 (2023).
doi: 10.3389/fnins.2023.1122235
pubmed: 36866331
pmcid: 9971723
Wang, R., He, M. & Xu, J. Serum bilirubin level correlates with mortality in patients with traumatic brain injury. Medicine 99(27), e21020. https://doi.org/10.1097/MD.0000000000021020 (2020).
doi: 10.1097/MD.0000000000021020
pubmed: 32629724
pmcid: 7337601
Marconi, V. et al. Bilirubin is inversely associated with cardiovascular disease among HIV-positive and HIV-negative individuals in VACS (Veterans Aging Cohort Study). J. Am. Heart Assoc. 7(10), e007792. https://doi.org/10.1161/JAHA.117.007792 (2018).
doi: 10.1161/JAHA.117.007792
pubmed: 29720501
pmcid: 6015337
Tian, X. et al. Association of serum bilirubin with stroke severity and clinical outcomes. Can. J. Neurol. Sci. 40(1), 80–84. https://doi.org/10.1017/s0317167100012993 (2013).
doi: 10.1017/s0317167100012993
Sun, L. et al. Bilirubin and stroke risk using a Mendelian randomization design. Stroke 48(5), 1154–1160. https://doi.org/10.1161/STROKEAHA.116.015083 (2017).
doi: 10.1161/STROKEAHA.116.015083
Sheng, X., Du, H. & Tang, Y. Decreased serum total bilirubin level predicts early neurological deterioration in patients with acute ischemic stroke. Neuropsychiatr. Dis. Treat. 17, 1977–1982 (2021).
doi: 10.2147/NDT.S315330
pubmed: 34168455
pmcid: 8216736
Duan, H. et al. Serum bilirubin associated with stroke severity and prognosis: Preliminary findings on liver function after acute ischemic stroke. Neeurol. Res. 45(1), 62–69 (2022).
doi: 10.1080/01616412.2022.2119724
Perlstein, T. et al. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999–2004. Am. J. Med. 121(9), 781–788 (2008).
doi: 10.1016/j.amjmed.2008.03.045
pubmed: 18724968
pmcid: 2596911
Wang, G. et al. Association between bilirubin levels and risk of stroke: A systematic review and meta-analysis. BMJ Open 13(5), e064433. https://doi.org/10.1136/bmjopen-2022-064433 (2023).
doi: 10.1136/bmjopen-2022-064433
pubmed: 37164466
pmcid: 10174027
Zhong, P. Bilirubin in physiologic concentration may be a protective factor for ischemic stroke. Biomed. J. Sci. Tech. Res. 38(4), 30495. https://doi.org/10.26717/bjstr.2021.38.006175 (2021).
doi: 10.26717/bjstr.2021.38.006175
Choi, Y. et al. Causal associations between serum bilirubin levels and decreased stroke risk: A two-sample Mendelian randomization study. Arterioscl. Therom. Vas. 40(2), 437–445 (2019).
doi: 10.1161/ATVBAHA.119.313055
Liu, H. et al. Pterostilbene attenuates astrocytic inflammation and neuronal oxidative injury after ischemia-reperfusion by inhibiting NF-kappaB phosphorylation. Front. Immunol. 10, 2408 (2019).
doi: 10.3389/fimmu.2019.02408
pubmed: 31681297
pmcid: 6811521
Petrovic-Djergovic, D., Goonewardena, S. N. & Pinsky, D. J. Inflammatory disequilibrium in stroke. Circ. Res. 119(1), 142–158 (2016).
doi: 10.1161/CIRCRESAHA.116.308022
pubmed: 27340273
pmcid: 5138050
Puca, F. et al. Medium-chain acyl-CoA dehydrogenase protects mitochondria from lipid peroxidation in glioblastoma. Cancer Discov. 11(11), 2904–2923 (2021).
doi: 10.1158/2159-8290.CD-20-1437
pubmed: 34039636
pmcid: 8711129
Doré, S. T. M. et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. USA 96(5), 2445–2450 (1999).
doi: 10.1073/pnas.96.5.2445
pubmed: 10051662
pmcid: 26804
Yao, Q. et al. Localized controlled release of bilirubin from beta-cyclodextrin-conjugated epsilon-polylysine to attenuate oxidative stress and inflammation in transplanted islets. ACS Appl. Mater Interfaces 12(5), 5462–5475 (2020).
doi: 10.1021/acsami.9b18986
pubmed: 31927945
Amor, A. J. et al. Relationship between total serum bilirubin levels and carotid and femoral atherosclerosis in familial dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 37(12), 2356–2363 (2017).
doi: 10.1161/ATVBAHA.117.310071
pubmed: 29074587